A scientist at the University of Oxford in Britain expected, today, Wednesday, that the regulatory authorities in Britain will license the use of the Corona virus vaccine, which the university is developing jointly with the pharmaceutical company, “AstraZeneca”, “shortly” after Christmas.
Professor Sir John Bell, professor of medicine at Oxford University, said that he expects the license of the Medicines and Healthcare Products Regulatory Agency to be issued “very soon,” according to what was reported by the British “Guardian” newspaper..
“They got the data a very long time ago, but this was the first set of data, and they’re receiving multiple sets of data, so we’re on the cusp of prime time now, and I’m expecting some news very soon,” Bell said.“.
“I doubt we’ll catch up with Christmas now, but right after Christmas is what I expect, and I have absolutely no worries that the data looks better than ever.”“.
The licensing of the “Oxford / AstraZeneca” vaccine would be a major boost to efforts to control Covid-19 because the process of distributing it would be easier than the “Pfizer / Biontech” vaccine currently used in the United Kingdom, according to the newspaper..
The newspaper pointed out that the British government requested 100 million doses of this vaccine, provided that about 40 million doses of it would be available by the end of next March..
AstraZeneca previously announced that its COVID-19 vaccine is 70 to 90% effective, based on interim results from large-scale clinical trials.
Source link